A recent study published in the Journal of Neuroimmune Pharmacology, and by the National Institute of Health, has found that delta-9-tetrahydrocannabinol (THC) – one of the prime compounds in cannabis – can potentially stop organ transplant rejections from taking place. The study, which found that the higher the dose of THC, the higher the chance of protecting …
Tag: neuroimmune pharmacology
- Here Are the 5 States Most Likely to Legalize Marijuana Next
- Medical Cannabis Use Associated With Reduced Opioid Use In Pain Patients, Finds Study
- Study: Marijuana Stores Associated With Increased Home Values
- U.S. Congress Approves Bill to Legalize Hemp, Sending it to President Trump
- New Zealand Parliament Approves Medical Marijuana Legislation
- California Officials Say Cannabis Deliveries Can Be Made Anywhere, Even in Cities Where Marijuana is Banned
- U.S. Surgeon General Says We Need to Reconsider How We Schedule Marijuana
- Study: CBD Reduces Airway Inflammation and Fibrosis in Experimental Allergic Asthma.
Thank you for reading TheJointBlog.com!